Gary Leong, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1800 Lawrence Dr, De Pere, WI 54115 Phone: 920-983-3220 |
Karla Jean Spika, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1686 Eisenhower Rd, De Pere, WI 54115 Phone: 920-496-4700 Fax: 920-431-1982 |
Cynthia B Lasecki, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Lawrence Dr, De Pere, WI 54115 Phone: 920-983-3220 |
Dr. Mary A Sauvey, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 Heritage Rd, Suite A, De Pere, WI 54115 Phone: 920-347-1990 Fax: 920-347-1991 |
Ann M Zellner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3860 Monroe Rd, De Pere, WI 54115 Phone: 920-496-4700 Fax: 920-496-4700 |
Dr. Alec Wilhelmi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1881 Chicago St, De Pere, WI 54115 Phone: 920-403-8000 Fax: 920-403-8202 |
Dr. Eric Mitchell Rojo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3860 Monroe Rd, De Pere, WI 54115 Phone: 920-496-4700 Fax: 920-272-1120 |
News Archive
Plans to design a smart phone app that can detect leukaemia will be among the innovations presented by Northumbria University researchers at the Centre for Life this weekend.
More than 30 states are opting to not build the insurance marketplaces that are at the center of the health overhaul, so the job will be left to the federal government.
How will the traumatic events of the terrorist attacks of 13 November 2015 evolve in people's memories, whether collective or individual? How does individual memory feed on collective memory and vice versa?
Bayer Radiology & Interventional announced the introduction of the Certegra Workstation, an informatics-driven, touchâscreen hub that enables time savings and improved patient care through a powerful suite of CT Contrast Dose Management applications and a new P3T 2.0 operating environment.
The Norwegian cardiovascular biopharmaceutical company Seordus AS today announced that the Japanese Patent Office has granted a patent for Japan covering Serodus' proprietary product SER100, an ORL-1 receptor agonist, which Serodus intends to develop for patients with isolated systolic hypertension.
› Verified 8 days ago